214eP Exploratory biomarkers evaluation to enhance characterization and explore treatment response prediction in metastatic ovarian cancer patients undergoing therapy with EVT801, a highly selective VEGFR-3 inhibitor.
Saved in:
| Title: | 214eP Exploratory biomarkers evaluation to enhance characterization and explore treatment response prediction in metastatic ovarian cancer patients undergoing therapy with EVT801, a highly selective VEGFR-3 inhibitor. |
|---|---|
| Authors: | Fons, P.1 (AUTHOR), Gomez-Roca, C.A.2 (AUTHOR), Cassier, P.3 (AUTHOR), Delord, J-P.2 (AUTHOR), Rochaix, P.4 (AUTHOR), Korakis, I.5 (AUTHOR), Leonardi, G.C.6 (AUTHOR), Hanvic, B.7 (AUTHOR), Tsoutzidis, N.8 (AUTHOR), Davenne, L.9 (AUTHOR), Mandron, M.10 (AUTHOR), Corsi, A.11 (AUTHOR), Verlingue, L.12 (AUTHOR), Meca, C.C.13 (AUTHOR), Fitzgerald, M.14 (AUTHOR), Friend, J.15 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 2, Vol. 36, pS290-S291. 2p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2025.08.646 |
